Interleukin-21 Inhibits Dendritic Cell-Mediated T Cell Activation and Induction of Contact Hypersensitivity In Vivo

Katja Brandt, Silvia Bulfone-Paus, André Jenckel, Donald C. Foster, Ralf Paus, René Rückert

Research output: Contribution to journalArticle

70 Citations (Scopus)

Abstract

Interleukin (IL)-21 is a newly described cytokine that is produced by activated T cells and displays structural homology to IL-4 and IL-15. We here analyzed the role of IL-21 in dendritic cell (DC)-induced, T cell-mediated contact hypersensitivity (CHS) in vivo and on T cell activation and unspecific mixed lymphocyte reaction in vitro. By PCR, we demonstrate here constitutive expression of the specific IL-21 receptor and the common γ-chain in DC, which together are able to mediate IL-21 signaling. Short-time incubation of in vitro generated DC with IL-21 significantly reduced their potential to induce an antigen-specific CD8+ T cell proliferation. Interestingly, 2h incubation of these DC with IL-21 before injection completely inhibited the potential of these DC to induce a CHS reaction to the hapten fluorescein 5-isothiocyanate in vivo. Mice injected with IL-21-treated DC even failed to mount a CHS response after repetitive injection of non-IL-21-treated DC 2 weeks later, suggesting that an antigen-specific unresponsiveness can be induced by IL-21-treated DC. Our data demonstrate that IL-21 is a new modulator of DC-T cell interaction with the potential to induce DC-mediated antigen-specific tolerance.

Original languageEnglish (US)
Pages (from-to)1379-1382
Number of pages4
JournalJournal of Investigative Dermatology
Volume121
Issue number6
DOIs
StatePublished - Jan 1 2003
Externally publishedYes

Fingerprint

T-cells
Contact Dermatitis
Dendritic Cells
Chemical activation
T-Lymphocytes
Antigens
Interleukin-21 Receptors
interleukin-21
CD8 Antigens
Interleukin-15
Mixed Lymphocyte Culture Test
Injections
Lymphocytes
Haptens
Fluorescein-5-isothiocyanate
Cell proliferation
Cell Communication
Interleukin-4
Modulators
Display devices

Keywords

  • Cytokines
  • Dendritic cells
  • Inflammation
  • T cells

ASJC Scopus subject areas

  • Biochemistry
  • Molecular Biology
  • Dermatology
  • Cell Biology

Cite this

Interleukin-21 Inhibits Dendritic Cell-Mediated T Cell Activation and Induction of Contact Hypersensitivity In Vivo. / Brandt, Katja; Bulfone-Paus, Silvia; Jenckel, André; Foster, Donald C.; Paus, Ralf; Rückert, René.

In: Journal of Investigative Dermatology, Vol. 121, No. 6, 01.01.2003, p. 1379-1382.

Research output: Contribution to journalArticle

Brandt, Katja ; Bulfone-Paus, Silvia ; Jenckel, André ; Foster, Donald C. ; Paus, Ralf ; Rückert, René. / Interleukin-21 Inhibits Dendritic Cell-Mediated T Cell Activation and Induction of Contact Hypersensitivity In Vivo. In: Journal of Investigative Dermatology. 2003 ; Vol. 121, No. 6. pp. 1379-1382.
@article{ebfe466ef37443c39b657c0a7549260c,
title = "Interleukin-21 Inhibits Dendritic Cell-Mediated T Cell Activation and Induction of Contact Hypersensitivity In Vivo",
abstract = "Interleukin (IL)-21 is a newly described cytokine that is produced by activated T cells and displays structural homology to IL-4 and IL-15. We here analyzed the role of IL-21 in dendritic cell (DC)-induced, T cell-mediated contact hypersensitivity (CHS) in vivo and on T cell activation and unspecific mixed lymphocyte reaction in vitro. By PCR, we demonstrate here constitutive expression of the specific IL-21 receptor and the common γ-chain in DC, which together are able to mediate IL-21 signaling. Short-time incubation of in vitro generated DC with IL-21 significantly reduced their potential to induce an antigen-specific CD8+ T cell proliferation. Interestingly, 2h incubation of these DC with IL-21 before injection completely inhibited the potential of these DC to induce a CHS reaction to the hapten fluorescein 5-isothiocyanate in vivo. Mice injected with IL-21-treated DC even failed to mount a CHS response after repetitive injection of non-IL-21-treated DC 2 weeks later, suggesting that an antigen-specific unresponsiveness can be induced by IL-21-treated DC. Our data demonstrate that IL-21 is a new modulator of DC-T cell interaction with the potential to induce DC-mediated antigen-specific tolerance.",
keywords = "Cytokines, Dendritic cells, Inflammation, T cells",
author = "Katja Brandt and Silvia Bulfone-Paus and Andr{\'e} Jenckel and Foster, {Donald C.} and Ralf Paus and Ren{\'e} R{\"u}ckert",
year = "2003",
month = "1",
day = "1",
doi = "10.1046/j.1523-1747.2003.12603.x",
language = "English (US)",
volume = "121",
pages = "1379--1382",
journal = "Journal of Investigative Dermatology",
issn = "0022-202X",
publisher = "Nature Publishing Group",
number = "6",

}

TY - JOUR

T1 - Interleukin-21 Inhibits Dendritic Cell-Mediated T Cell Activation and Induction of Contact Hypersensitivity In Vivo

AU - Brandt, Katja

AU - Bulfone-Paus, Silvia

AU - Jenckel, André

AU - Foster, Donald C.

AU - Paus, Ralf

AU - Rückert, René

PY - 2003/1/1

Y1 - 2003/1/1

N2 - Interleukin (IL)-21 is a newly described cytokine that is produced by activated T cells and displays structural homology to IL-4 and IL-15. We here analyzed the role of IL-21 in dendritic cell (DC)-induced, T cell-mediated contact hypersensitivity (CHS) in vivo and on T cell activation and unspecific mixed lymphocyte reaction in vitro. By PCR, we demonstrate here constitutive expression of the specific IL-21 receptor and the common γ-chain in DC, which together are able to mediate IL-21 signaling. Short-time incubation of in vitro generated DC with IL-21 significantly reduced their potential to induce an antigen-specific CD8+ T cell proliferation. Interestingly, 2h incubation of these DC with IL-21 before injection completely inhibited the potential of these DC to induce a CHS reaction to the hapten fluorescein 5-isothiocyanate in vivo. Mice injected with IL-21-treated DC even failed to mount a CHS response after repetitive injection of non-IL-21-treated DC 2 weeks later, suggesting that an antigen-specific unresponsiveness can be induced by IL-21-treated DC. Our data demonstrate that IL-21 is a new modulator of DC-T cell interaction with the potential to induce DC-mediated antigen-specific tolerance.

AB - Interleukin (IL)-21 is a newly described cytokine that is produced by activated T cells and displays structural homology to IL-4 and IL-15. We here analyzed the role of IL-21 in dendritic cell (DC)-induced, T cell-mediated contact hypersensitivity (CHS) in vivo and on T cell activation and unspecific mixed lymphocyte reaction in vitro. By PCR, we demonstrate here constitutive expression of the specific IL-21 receptor and the common γ-chain in DC, which together are able to mediate IL-21 signaling. Short-time incubation of in vitro generated DC with IL-21 significantly reduced their potential to induce an antigen-specific CD8+ T cell proliferation. Interestingly, 2h incubation of these DC with IL-21 before injection completely inhibited the potential of these DC to induce a CHS reaction to the hapten fluorescein 5-isothiocyanate in vivo. Mice injected with IL-21-treated DC even failed to mount a CHS response after repetitive injection of non-IL-21-treated DC 2 weeks later, suggesting that an antigen-specific unresponsiveness can be induced by IL-21-treated DC. Our data demonstrate that IL-21 is a new modulator of DC-T cell interaction with the potential to induce DC-mediated antigen-specific tolerance.

KW - Cytokines

KW - Dendritic cells

KW - Inflammation

KW - T cells

UR - http://www.scopus.com/inward/record.url?scp=0346993779&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0346993779&partnerID=8YFLogxK

U2 - 10.1046/j.1523-1747.2003.12603.x

DO - 10.1046/j.1523-1747.2003.12603.x

M3 - Article

C2 - 14675186

AN - SCOPUS:0346993779

VL - 121

SP - 1379

EP - 1382

JO - Journal of Investigative Dermatology

JF - Journal of Investigative Dermatology

SN - 0022-202X

IS - 6

ER -